Subcutaneous Vaccination of Mycobacterium bovis Bacillus Calmette-Guerin Attenuates Allergic Inflammation in a Murine Model of Asthma

DOI Web Site Web Site 2 Citations 74 References Open Access
  • Ito Toshihiro
    Second Department of Internal Medicine, Nara Medical University
  • Hamada Kaoru
    Second Department of Internal Medicine, Nara Medical University
  • Suzaki Yasue
    Second Department of Internal Medicine, Nara Medical University
  • Matsui Norio
    Department of Bacteriology, Nara Medical University
  • Kita Eiji
    Department of Bacteriology, Nara Medical University
  • Kimura Hiroshi
    Second Department of Internal Medicine, Nara Medical University

Bibliographic Information

Other Title
  • Subcutaneous Vaccination of Mycobacterium bovis Bacillus Calmette-Guérin Attenuates Allergic Inflammation in a Murine Model of Asthma
  • Subcautaneous vaccination of Mycobacterium bovis Bacillus Calmette-Guerin attenuates allergic inflammation in a murine model of asthma.

Search this article

Description

Background: The increase in the incidence of allergic disorders especially in developed countries may be explained by the hygiene hypothesis. A novel therapeutic approach that causes a Th1-dominant response under conditions of Th2-skewed immunity has been investigated. Mycobacterium bovis Bacillus Calmette-Guérin (BCG) is a widely used anti-tuberculosis vaccine that strongly induces a Th1-predominant immune response. A potential role for BCG in the treatment of allergic diseases has been reported. In the present study, we investigated whether subcutaneous inoculation with a low dose (1 × 105) of BCG vaccine can attenuate allergic inflammation of the airway in a murine model of asthma.<br> Methods: Female BALB/c mice were vaccinated on day 0 with a subcutaneous. injection of 1 × 105 CFU of BCG, and sensitized to ovalbumin (OVA, i.p., with alum) on day 7 and 14, respectively. After a 2-week interval, they were exposed to aerosolized OVA (1%). In another experiment, BCG-sensitized splenic CD4+ T cells were adoptively transferred before sensitization.<br> Results: We found that BCG-vaccinated mice had fewer eosinophils in BALF and less severe allergic inflammation. The expression of IL-4 as well as Eotaxin and TARC was down-regulated in the vaccinated mice, while that of both IL-12 and IFN-γ was up-regulated. Moreover, the transfer of splenic CD4+ T cells from vaccinated mice into naïve mice before OVA-sensitization prevented the development of allergic inflammation. These splenic CD4+ T cells produced much IFN-γ.<br> Conclusions: The subcutaneous administration of (low-dose) BCG vaccine suppressed allergic inflammation via Th1-skewed immunity and might have clinical applications in immunotherapy for asthma.<br>

Journal

Citations (2)*help

See more

References(74)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top